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ABSTRACT 
Background Asthma is currently divided into different phenotypes, with age at onset as a 
relevant differentiating factor. In addition, asthma with onset in adulthood seems to have a 
poorer prognosis, but studies investigating age-specific incidence of asthma with a wide 
age span are scarce. 
Objective To evaluate incidence of asthma diagnosis at different ages and differences 
between child- and adult-diagnosed asthma in a large population-based study, with 
gender-specific analyzes included. 
Methods In 2016, a respiratory questionnaire was sent to 8000 randomly selected 
subjects aged 20-69 years in western Finland. After two reminders, 4173 (52.3%) subjects 
responded. Incidence rate of asthma was retrospectively estimated based on the reported 
age of asthma onset. Adult-diagnosed asthma was defined as physician-diagnosis of 
. 
Results Among those with asthma, altogether, 63.7% of subjects, 58.4% of men and 
67.8% of women, reported adult-diagnosed asthma. Incidence of asthma diagnosis was 
calculated in 10-year age groups and it peaked in young boys (0-9 years) and middle-aged 
women (40-49 years) and the average incidence rate during the examined period between 
1946 and 2015 was 2.2/1000/year. Adult-diagnosed asthma became the dominant 
phenotype among asthmatics by age of 50 years and 38 years in men and women, 
respectively. 
Conclusions Asthma is mainly diagnosed during adulthood and the incidence of asthma 
diagnosis peaks in middle-aged women. Asthma diagnosed in adulthood should be 
considered more in clinical practice and management guidelines. 
INTRODUCTION 
The recent re-identification of phenotypes has increased awareness of asthma as a 
heterogeneous disease1,2. Phenotypes are distinguished by age of asthma onset1,2, and 
asthma with onset later in life seems to have a poorer prognosis1,3,4. Epidemiological 
factors associated with asthma and wheezing at early age are well established5,6. 
However, less is known about incidence as the examined age span is widened to late 
adulthood. 
A substantial incidence of wheezing in childhood with a high remission rate is described by 
several cohort studies6-8. For instance, in the Tucson cohort 50% of subjects experienced 
at least one episode of wheezing during preschool age and 9.6% had been diagnosed with 
asthma at 6 years of age9, which stands for an average incidence of physician-diagnosed 
asthma of 16/1000/year during preschool age. Atopy and male gender are commonly 
reported risk factors for wheezing in childhood7,9-11. After preschool age, the incidence of 
asthma declines7,11,12, especially in boys13,14. 
The few longitudinal studies about adult-onset asthma have mostly reported the incidence 
to be 1.4-5/1000/year and higher in women15-20. Studies have varying age spans and the 
incidence in older subjects is less studied, although increasing incidence with age after 
mid-adulthood has been described14,15,17. Further, recent results from the US suggest that 
adult-onset asthma becomes the dominant phenotype in women quite early, at age 40 
years21, and novel data based on the entire population of Finland show similar results13. 
Nevertheless, further evidence is needed for verification of age-specific asthma incidence 
especially in subjects over 40 years of age. Therefore, the aim of this study was to 
evaluate gender-specific incidence of asthma diagnosis at different ages in a large 
population-based random sample of adults. 
METHODS 
Data acquisition 
As a part of the FinEsS (Finland-Estonia-Sweden) -study, a respiratory questionnaire was 
sent to a random sample of 8000 subjects aged 20-69 years in western Finland (the 
hospital district areas of South Ostrobothnia and Vaasa, with about 200 000 and 170 000 
inhabitants in 2016, respectively) in February 2016. The study area is mainly rural 
containing two major towns, Seinäjoki and Vaasa. Both elderly and bilinguals (Finnish and 
Swedish) are numerous in the population. Subjects and their personal details were 
identified from the Finnish Population Register, and the sample reflected age and sex 
distribution of the population in the study area. Up to three postal rounds were carried out 
or until a response was got. The registered native language of each subject determined 
whether questionnaire in Finnish or Swedish was applied. Subjects with other native 
languages were sent a Finnish questionnaire on the two first rounds and a Swedish 
questionnaire on the third round. 
The current study was approved by the ethics committee of Helsinki University Hospital. 
Concurrently with this study a similar FinEsS-study was conducted in Helsinki with 
identical questionnaire and corresponding protocols. 
Questionnaire 
The FinEsS questionnaire (FQ) is developed from the Obstructive Lung Disease in 
Northern Sweden (OLIN) questionnaire, which is modified from the Swedish version of the 
British Medical Research Council (BMRC) questionnaire22. FQ comprises questions on 
respiratory symptoms and diseases, their comorbidities and suggested risk factors, use of 
medication and occupation, and it has been previously used in several Nordic and 
Estonian studies17,23,24. 
Definition of key parameters 
Physician-diagnosed allergy 
diagnosed by a doctor as having allergic rhinitis caused by pollen (caused by e.g. birch, 
grass, mugwort)  or Have you been diagnosed by a doctor as having other allergic 
rhinitis (caused by e.g. cat or dog, but not caused by pollen)?  A positive response to 
of physician-diagnosed asthma, and age at asthma diagnosis was assessed with question 
age was defined as adult-diagnosed asthma, and before 18 years of age as child-
diagnosed asthma. A sensitivity analysis was conducted with adult-diagnosed asthma 
ears of age. Prevalence of asthma was defined as 
the proportion of responders reporting physician-diagnosed asthma. 
Incidence of asthma diagnosis was assessed in 10-year age groups in cross-sectional 
data, as previously described25. Briefly, subjects were separated into 10-year age groups 
based on their current age, and new asthma diagnoses/1000/year  was calculated by 
dividing the number of incident asthma diagnoses in each group by age-group-specific 
population at risk, dividing the result by 10 and finally multiplying with 1000. 
Each 10-year age group -specific population at risk was a mean value of annually 
calculated respective 10-year risks. With respect to age 0, all responders were at risk. For 
ages 1 to 20 years, subjects reporting asthma diagnosed at younger age than the age in 
question were annually subtracted from the original population at risk (i.e. all responders) 
to form 1-year populations at risk. 20 years was the age of the youngest responders. 
Therefore, asthma-naïve responders younger than the age for which the population at risk 
was calculated were further subtracted from all responders to assess populations at risk 
for ages 21-69. This subtraction procedure was applied, since responders could not have
reported asthma diagnosis at older age than themselves at the time of response. Asthma-
naïve responders were responders not reporting physician-diagnosed asthma. Assessing 
overall incidence, denominator for all diagnosed asthma cases was an average of annual 
populations at risk, and the result was further divided by 70, which was the length of the 
examined period in years. Subjects reporting physician-diagnosed asthma but not the age 
at diagnosis were excluded from incidence calculations. 
Subjects with incomplete smoking data were included in non-responder analyses but 
excluded from all other analyses to allow comparison of the results with Helsinki FinEsS-
data. 
Statistical analyses 
Statistical analyses were performed using SPSS statistics version 23 and 95% confidence 
intervals (CI) were calculated with EpiTools (http://epitools.ausvet.com.au) using the 
Wilson method, which allows CI calculation for relative proportions26. Percentage ranges in 
parentheses reflect CI. The distributions of continuous variables were evaluated, and when 
normally distributed, shown were mean (SD) and when non-normally distributed, shown 
were median (IQR). A Mann-Whitney U -test was used for continuous and chi-square -test 
for categorical variables to test between groups, and a p-value of < 0.05 was considered 
significant. 
Figure 1. Flow chart of the study. 
Random sample 
n=8000 invited 
Corrected random sample 
n=7986 invited 
Excluded from original 
sample 
n=14 unknown address 
Non-analyzable data 
n=38 returned empty 
n=6 wrong person (spouse etc.) 
Non-responders (included in 
the non-responder analysis) 
n=3769 
Responders 
n=4173 
(Response rate: 
4173/7986=52.3 %) 
Subjects with incomplete data 
on smoking 
n=206 
Subjects included in the 
analyses 
n=3967 
RESULTS 
Characteristics of responders and prevalence of asthma 
Of the 8000 invited subjects, 4173 (52.3%) responded. Median age of the responders was 
53 years (Table 1). The responders were more often women (52.6% vs. 44.5%) and older 
(median age 53 vs. 40 years) compared to the non-responders. 
Table 1. Basic characteristics of responders. 
 All, N=4173 Men, N=1976  Women, N=2197 
Age (yrs), median (IQR)  53  (38-63)  54  (39-63)  53  (38-63) 
BMI (kg/m2), mean (SD) 26.7  (4.9) 27.2  (4.4) 26.3  (5.2)
Native language, n (%) 
 Finnish 
 Swedish 
 Other 
2932  70.3 
1132  27.1 
109  2.6 
1368  69.2 
554  28.0 
54  2.7 
1564  71.2
578  26.3
55  2.5
Physician-diagnosed 
allergy, n (%) 745  17.9 316  16.0 429  19.5
Smoking, n (%) 
 Current 
 Ex 
 Never 
798  20.1 
1086  27.4 
2083  52.5 
471  24.8 
635  33.5 
792  41.7 
327  15.8
451  21.8
1291  62.4
Family history of asthma, 
n (%) 1058  25.4 406  20.5 652  29.7
Physician-diagnosed chronic 
bronchitis or COPD, n (%) 107  2.6 59  3.0 48  2.2
Living in rural area < 5 years 
of age, n (%) 2859  70.1 1371  71.1 1488  69.2
BMI is based on responses of 4070 in all, 1932 in male and 2138 in female, smoking of 3967 in all, 1898 in 
male and 2069 in female, and rural childhood of 4080 in all, 1929 in male and 2151 in female subjects. 
IQR=interquartile range, SD=standard deviation. 
After exclusion of subjects with incomplete smoking data (n=206), 445 of 3967 subjects 
(11.2%, 10.3-12.2%) reported physician-diagnosed asthma. Further, physician-diagnosed 
asthma was reported by 192 of 1898 men (10.1%, 8.8-11.6%) and 253 of 2069 women 
(12.2%, 10.9-13.7%). 706 subjects reported physician-diagnosed allergy which resulted in 
prevalence of 17.8% (16.6-19.0%). Of subjects reporting physician-diagnosed asthma 88 
(19.8%) were current smokers and 149 (33.5%) ex-smokers. Further, incident asthma was 
significantly associated with BMI in all subjects and women (Table 2 and Table 3). 
Smoking and BMI data in subjects categorized by age under or over 50 years was 
reported in detail in the Online Repository. 
Table 2. Prevalence of physician-diagnosed asthma in different subgroups and 
comparison of responders with and without physician-diagnosed asthma. 
Prevalence 
of asthma 
in given 
subgroups 
(%) N=3967 
Responders with 
physician-
diagnosed 
asthma  
N=445 
Responders 
without 
physician-
diagnosed 
asthma N=3522 
P-value 
Age (yrs), median (IQR) N/D  51     (35-63)  53     (38-63) 0.113 
Gender, n (%) 
Male 
Female 
10.1 
12.2 
192  43.1 
253  56.9 
1706  48.4 
1816  51.6 
0.035 
BMI (kg/m2), mean (SD) N/D 27.4     (5.5) 26.6     (4.8) 0.020 
Smoking, n (%) 
Current 
Ex 
Never 
11.0 
13.7 
10.0 
88  19.8 
149  33.5 
208  46.7 
710  20.2 
937  26.6 
1875  53.2 
0.007 
Family history of asthma, n (%) 
Yes 
No 
20.6 
8.0 
208  46.7 
237  53.3 
802  22.8 
2720  77.2 
<0.001 
Physician-diagnosed chronic 
bronchitis or COPD, n (%) 
Yes 
No 
43.4 
10.4 
43  9.7 
402  90.3 
56  1.6 
3466  98.4 
<0.001 
BMI is based on responses of 3886 subjects. Gender-specific values have been calculated on the total of 
male and female subjects. IQR=interquartile range, SD=standard deviation. 
Table 3. Gender-specific comparison of subjects in relation to physician-diagnosed 
asthma. 
Men N=1898 
Physician-diagnosed asthma 
Yes N=192       No N=1706 
P-value Women N=2069 
Physician-diagnosed asthma 
Yes N=253       No N=1816 
P-value 
Age (yrs), median (IQR)  50  (34-63)     54  (40-63) 0.806  52  (35-64)  52  (38-62) 0.040
BMI (kg/m2), mean (SD) 27.9  (5.3)  27.1  (4.3) 0.333 27.1  (5.7)  26.2  (5.1) 0.018
Smoking, n (%) 
Current 
Ex 
Never 
45  23.4  426  25.0 
76  39.6  559  32.8 
71  37.0  721  42.3 
0.156 
43  17.0  284  15.6 
73  28.9  378  20.8 
 137  54.2  1154  63.5 
0.007
Family history of 
asthma, n (%) 78  40.6  312  18.3 
 <0.001 
130  51.4  490  27.0 
  <0.001
Physician-diagnosed 
chronic bronchitis or 
COPD n (%) 24  12.5  30  1.8 
 <0.001 
19  7.5  26  1.4 
<0.001
BMI is based on responses of 1864 subjects in men and 2022 in women. IQR=interquartile range, 
SD=standard deviation. 
Age at diagnosis of asthma 
In total, 427 subjects reporting physician-diagnosed asthma, 185 men and 242 women, 
reported also the age at asthma diagnosis. Median age at diagnosis was 21 (IQR 7-43) 
years in men and 30 (IQR 15-45) years in women (p=0.026). Altogether, 36.3% of 
asthmatics (31.9-41.0%) reported being diagnosed with asthma in childhood (< 18 years) 
and 63.7% (59.0-68.1%) 2). Men were diagnosed with 
asthma more often during childhood than women: 41.6% (34.8-48.8%) versus 32.2% 
(26.7-38.4%), respectively (p=0.046). Accordingly, the proportions of adult-diagnosed 
asthma were 58.4% (51.2-65.2%) in men, and 67.8% (61.6-73.3%) in women. A sensitivity 
analysis using a cut-point at 15 years also indicated prominence of adult-diagnosed 
asthma (see t
Figure 2. Gender-specific proportions of asthma diagnosed during childhood and 
adulthood with 95% CI:s. 
After excluding subjects who reported physician-diagnosed asthma but not the age at 
diagnosis (n=18), incidence was calculated in 10-year age groups (Figure 3). In men, 
incidence peaked in childhood and was followed by a low and flat rate in adolescence and 
early adulthood with a slight upward trend towards late adulthood. In women, a stable 
trend was interrupted by a high peak in mid-adulthood (40-49 years) following a 
descending trend towards the oldest age group (60-69 years). On average, the incidence 
rate was 2.2/1000/year. Gender-specific incidence of child- and adult-diagnosed asthma 
are presented in Table 4. An analysis of decennial incidence of new asthma diagnosis 
showed increasing incidence during the whole inspected period from 1946 to 2015 (see 
this article´s Online Repository).  
Figure 3. Age- and gender-specific incidence rates of new asthma diagnosis with 95% 
CI:s. 
Table 4. Gender-specific incidence rates of child- and adult-diagnosed asthma. 
Incidence/1000/year All Men Women 
Overall 2.2 2.0 2.4 
Child-diagnosed (<18) 2.2 2.3 2.1 
Adult- 2.2 1.8 2.6 
The number of adult-diagnosed asthma exceeded the number of child-diagnosed asthma 
i.e. became the dominant phenotype in women by age 38 years and in men by age 50 
years (Figure 4). 
Figure 4. The ratio of adult-diagnosed asthma in relation to child-diagnosed asthma in 
males and females. At the age point that the curve crosses level 1, adult-diagnosed 
asthma becomes the dominant phenotype. 
Validation of the main result 
Data from Helsinki, collected with equal methods concurrently with the current study, was 
compared to our data from western Finland. In western Finland the proportions of child-
diagnosed and adult-diagnosed asthma were 36.3% and 63.7%, respectively, as 
described above, and the corresponding proportions in Helsinki were 45.1% (40.2-50.0%) 
and 54.9% (50.0-59.8%), respectively. 
DISCUSSION 
In this random population sample of adults, asthma diagnosis at adult age was more 
common than diagnosis in childhood. The incidence peaked in young boys (0-9 years) and 
middle-aged women (40-49 years). Finally, adult-diagnosed asthma became the dominant 
phenotype by age 50 and 38 years in men and women, respectively. 
Prevalence of physician-diagnosed asthma was 11.2% and is similar with novel reports 
from Nordic studies27,28. Prevalence was higher in boys than girls but higher in women 
than men and the gender reversal occurred in adolescence, as previously described10,13. 
The prevalence of physician-diagnosed allergy was 17.8%, and a recent Finnish study 
estimated it somewhat higher, but it assessed self-reported allergy27. Allergy prevalence 
varies notably between studies depending on the area and definition29.  
Incidence of asthma diagnosis in 0-18-year-old children was 2.2/1000/year, being low 
compared to prospective studies6-8 which generally produce higher incidence estimates7,12. 
Reporting asthma onset is found to be less sensitive retrospectively30,31, implying that 
milder asthma is left out. In addition, child-onset asthma is particularly sensitive to recall 
bias since in three out of four school-aged children asthma remits by mid-adulthood6,32. 
Thus, the incidence may be higher than reported here. However, our subjects reported 
age at asthma diagnosis which is invariably based on objective lung function testing in 
Finland, as the national guidelines require13,33. Therefore, the share of false positives is 
lower. In conclusion, we consider that child-diagnosed cases are reliable but represent 
more persistent and severe asthma, which corresponds to adult-diagnosed asthma that is 
less often mild1-4.  
Overall adult-diagnosed asthma incidence was 2.2/1000/year, well in line with three large 
adult incidence studies from Sweden performed 1985-2006 each with about 10-year 
follow-up16,19,20, and also with most other adult-onset asthma studies15,18. Asthma 
diagnosis is associated with special asthma medication reimbursement and state-funded 
financial benefits in Finland13, resulting better recall of asthma diagnosis in adults. 
Furthermore, self-reported asthma onset reportedly has a very good specificity30,31. In 
conclusion, we consider adult-diagnosed asthma cases reliable and the number of 
reported diagnoses comprehensive. 
Overall incidence during 1946-2015 was 2.2/1000/year in parallel to one study that 
reached > 50-year-old subjects13, and another with a narrower age span but similar setting 
as the current study14. Further, age-specific incidence was higher in boys (0-9 years), 
equal in both genders during adolescence (10-19 years), and after that remained higher in 
women, also in parallel with earlier findings10,12,13,25. Boys are more prone to develop 
asthma in childhood7,9, but persistence is associated with female gender6,8, and sex 
hormones may cause susceptibility to different environmental factors10,34. The age- and 
gender-centered risk assessment seems to differentiate the patients well, and utilizing 
such simple characterization new asthma onset is easier to identify. This may result in less 
overlook and shorter delay of asthma diagnosis. Therefore, complications will be avoided 
and the quality of life in patients enhanced. As asthma is common in the population and 
over 200,000 people possessed right to asthma reimbursement in Finland in 201313, 
financial burden would consequently be significantly lessened. 
Age-specific incidence rose towards late adulthood, as described earlier, but controversial 
results do also exist15,18,20. Incidence was particularly high in middle-aged women, and 
quite similar findings are reported20,25. It may be reflecting hormonal changes in mid-
adulthood, such as menopause, which is recently identified as a strong predictor of asthma 
in women not using exogenous hormones35. In addition, one often reported adult-onset 
asthma phenotype is obesity-related, consisting more female subjects with later onset 
asthma (> 40 years)2,36. Interestingly, BMI was also associated with the incidence of 
asthma in this study, in line with other Scandinavian studies37. Nevertheless, this 
phenomenon in women is significant and should be further investigated. 
Proportion of adult-diagnosed asthma was higher than child-diagnosed, confirmed with 
Helsinki data. The result is in line with another study13, which examined the whole age 
span and had an equivalent cut-point to our study (at 18 years). Since we had different 
aged responders and although asthma can be 
found at any age38, adult-diagnosed group lacked person-years and therefore 
underestimated the number of adult diagnoses. Nevertheless, our data probably 
underestimate the proportion of child-onset asthma and distinction between the two 
phenotypes might be overestimated. However, similar data for 70 years would be difficult 
to collect prospectively, and our data clearly describes adult-onset asthma as a notable 
phenomenon. 
Understanding different asthma etiologies and their relative probabilities regarding age at 
onset in adult patients is important for physicians especially if the era of asthma 
phenotyping proceeds to clinical work. In our study, adult-onset asthma became the 
dominant phenotype in women by age 38 years, in line with two earlier reports13,21. A study 
from the US defined adult-
whereas a Finnish study used a cut-point at 15 years13,21. The US study reported that 
child-onset asthma was still the dominant phenotype in 50-year-old men, differing from our 
result21. Averagely shorter recall periods and prospective design, leading to inclusion of 
mild asthma in the US study may explain the slightly different result. However, our result 
regarding men is in line with those of the previous Finnish study13, which only included 
patients who had been granted with a special medication reimbursement, indicating that all 
patients had objectively diagnosed, more persistent asthma. 
Smoking has been associated with asthma in incidence studies20, while most cross-
sectional studies have found association with ex-smoking28,39 similarly to this study. This is 
: bias caused by smoking cessation 
because of excessive respiratory symptoms and asthma diagnosis16. In addition, asthma-
COPD overlap (ACO) is recently identified40. Patients with asthma smoke as often as non-
asthmatics and in adult asthma populations many have at least some smoking 
history3,28,36,38. In previous adult asthma studies the exclusion of current smokers or 
patients with smoking history might lower the incidence estimates in adults, and the 
influence is emphasized in women, in whom smoking is a higher risk factor for asthma 
onset39. In Finland COPD is diagnosed with objective lung function tests which serve as a 
basis for medication reimbursement, similarly as in asthma13,33. Nevertheless, we cannot 
exclude some misclassification between asthma and COPD, especially in elderly patients, 
since COPD usually occurs after 50 years of age. However, the majority of patients with 
asthma diagnosed > 40 years of age were women, in which significant smoking history is 
less common in Finland41. Thus, we consider that the bias due to misclassification of 
COPD as asthma does not explain the higher numbers of newly-diagnosed asthma in 
older women.  
In the last three decades, over 130 birth cohorts on asthma and allergies have been 
initiated5. In contrast, similar adult cohort studies are scarce. Although some birth cohorts 
suggest that adult-onset asthma may have manifested in childhood5,7, adult- and child-
onset asthma have highly distinct characteristics and treatment response, implying that it 
may be appropriate to study them as separate entities1,2,42. In addition, adult-onset asthma 
is more often associated with environmental risk factors, implying that substantial potential 
for prevention exists42. In a clinical study with population from the same area as in the 
current study, 24% of adult patients with verified new-onset asthma had had asthma 
symptoms in childhood36 and a case-control study from Sweden found that approximately 
10% of subjects with recently diagnosed asthma had been symptomatic before37. 
Therefore, it is justified to assume that most of adult-diagnosed asthma in the current 
study is also adult-onset asthma. Further, making asthma diagnosis in young children is 
complex due to lack of appropriate lung function tests and although the incidence of 
wheezing is substantial, it should not be too eagerly classified as asthma43. Furthermore, 
not every early wheezer develops asthma in adulthood, and neither does every adult-
diagnosed asthma patient have wheezing history7. Small airway caliber and viral infections 
can also act as confounders9. In conclusion, we believe that adult-onset asthma is a 
separate entity with unidentified potential for prevention. It should not usually be 
considered as a reactivation of child-onset asthma, or having similar characteristics. 
The response rate in the present study was 52.3%, being moderate, considering that 
response rates in respiratory epidemiology have declined during the last decades44,45. 
Studies investigating nonresponse bias have found non- and late responders to differ from 
initial responders by being more often males, younger people and current smokers, 
correspondingly with the data available in this study16,44,45. In addition, these studies report 
varying results on differences between proportion of asthmatics in responders versus non-
and late responders. However, none of these studies stated that using reminders or 
nonresponse bias significantly affected the prevalence or odds ratios related to asthma, 
even if the response rate was < 50%. A telephone interview non-responder study was 
planned as a part of the current study, but ethical permission was not granted. 
Nevertheless, we conclude that this study might have included some non-responder bias, 
which mainly affects younger and males. 
The main weaknesses of the current study are as follows. Firstly, recall bias is present due 
to the long recall periods in some asthma cases. Secondly, our responders were more 
often older and women and therefore results are susceptible to nonresponse bias. Thirdly, 
Finally, due to the inclusion of subjects 
with significant smoking history, we probably interpreted some COPD as asthma in older 
subjects. However, the present study also has many strengths. We had a large sample 
reflecting general population and a relatively good response rate, and used a 
questionnaire with well proven validity. Subjects were asked about physician-diagnosed 
asthma which is diagnosed with objective methods and associated to financial benefits in 
Finland, diminishing recall bias and securing better validity of asthma cases. Lastly, we 
had a very wide age span which would be extremely difficult to achieve without major drop 
out prospectively. 
In conclusion, adult-onset asthma is a common phenotype and a major burden to the 
healthcare system. The incidence of adult-onset asthma peaks in middle-aged women. By 
investigating the poorly understood etiology of new asthma in adult subjects, new 
approaches to pathogenesis, preventive strategies and effective treatment methods could 
be discovered. This would lead to upgraded guidelines and major economical and public 
health improvements. 
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